NeueHealth Inc (NEUE) FinancialsNEUENeueHealth Inc

NeueHealth Inc (NEUE) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Neuecare, accounting for 59.1% of total sales, equivalent to $127.61M. Other significant revenue streams include Neuesolutions and Eliminations. Understanding this composition is critical for investors evaluating how NEUE navigates market cycles within the Life & Health Insurance industry.

Evaluating the bottom line, NeueHealth Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 6.43%, while the net margin is 3.27%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively NEUE converts its operational activities into shareholder value.

In the context of the broader market, NEUE competes directly with industry leaders such as TBRG and ALHC. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, NEUE's gross margin of N/A stands against TBRG's 47.59% and ALHC's 12.96%. Such benchmarking helps identify whether NeueHealth Inc is trading at a premium or discount relative to its financial performance.